About Us
Management
Board of Directors
Job Opportunities
Pipeline
AGB101 for MCI due to AD
About MCI due to Alzheimer’s Disease
Novel GABA(A) α5 Discovery Program
The Science
Newsroom
Publications
Investor Relations
Patient Resources
MCI due to Alzheimer’s Disease
Autism
Schizophrenia
Toggle navigation
From the Lab
Our Science
Our Science
Learn why AgeneBio targets the hippocampus, the key driver of MCI due to AD.
Read More
